Inhibrx Biosciences, Inc.
INBX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002007919
In the last 90 days, Inhibrx Biosciences, Inc. insiders filed 6 open-market purchases and 2 sales; 162 institutions reported holding it in 13F filings for Q2 2026, worth $1.36B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Inhibrx Biosciences, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- 0 vs. Q4 2023
- Shares held
- 38.3M
- −2.30M (−5.7%) vs. Q4 2023
- Total value
- $1.34B
- −$203.6M (−13.2%) vs. Q4 2023
- New holders
- 27
- 38 more added
- Sold out
- 27
- 38 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 162 | $1.36B |
| Q1 2026 | 135 | $854.6M |
| Q4 2025 | 138 | $1.01B |
| Q3 2025 | 102 | $353.6M |
| Q2 2025 | 89 | $148.9M |
| Q1 2025 | 92 | $151.0M |
| Q4 2024 | 101 | $171.9M |
| Q3 2024 | 96 | $139.3M |
| Q2 2024 | 88 | $137.9M |
| Q1 2024 | 126 | $1.34B |
| Q4 2023 | 126 | $1.54B |
| Q3 2023 | 111 | $716.1M |
| Q2 2023 | 107 | $935.2M |
| Q1 2023 | 108 | $691.6M |
| Q4 2022 | 116 | $886.0M |
| Q3 2022 | 102 | $512.2M |
| Q2 2022 | 100 | $297.3M |
| Q1 2022 | 99 | $548.0M |
| Q4 2021 | 101 | $1.01B |
| Q3 2021 | 66 | $681.6M |
| Q2 2021 | 61 | $538.8M |
| Q1 2021 | 55 | $326.3M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Inhibrx Biosciences, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Advisers, LP | 282,000 | $9.86M | 0.02% | +71,200+33.8% | Added |
| Barclays PLC | 282,303 | $9.87M | 0.00% | +193,438+217.7% | Added |
| Northern Trust Corp | 307,541 | $10.8M | 0.00% | −6,348−2.0% | Reduced |
| Citigroup Inc | 331,302 | $11.6M | 0.01% | +286,612+641.3% | Added |
| TIG Advisors, LLC | 333,988 | $11.7M | 1.36% | +333,988 | New |
| Goldman Sachs Group Inc | 376,540 | $13.2M | 0.00% | +223,360+145.8% | Added |
| Slotnik Capital, LLC | 419,778 | $14.7M | 9.48% | +419,778 | New |
| UBS Group AG | 445,197 | $15.6M | 0.01% | +364,412+451.1% | Added |
| MMCAP International Inc. SPC | 451,433 | $15.8M | 2.05% | +451,433 | New |
| Qube Research & Technologies Ltd | 542,971 | $19.0M | 0.03% | +502,472+1,240.7% | Added |
| Morgan Stanley | 549,469 | $19.2M | 0.00% | +252,550+85.1% | Added |
| Tang Capital Management LLC | 700,000 | $24.5M | 2.55% | +700,000 | New |
| Geode Capital Management, LLC | 704,825 | $24.6M | 0.00% | +17,465+2.5% | Added |
| Bank of America Corp | 741,591 | $25.9M | 0.00% | +48,611+7.0% | Added |
| Walleye Capital LLC | 800,000 | $28.0M | 0.30% | +800,000 | New |
| ArrowMark Colorado Holdings LLC | 891,220 | $31.2M | 0.35% | −65,661−6.9% | Reduced |
| Alpine Associates Management Inc. | 1,054,475 | $36.9M | 1.44% | +1,054,475 | New |
| Citadel Advisors LLC | 1,204,252 | $42.1M | 0.04% | +949,414+372.6% | Added |
| Sofinnova Investments, Inc. | 1,302,645 | $45.5M | 2.69% | +529,688+68.5% | Added |
| TCG Crossover Management, LLC | 1,750,387 | $61.2M | 4.84% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,861,469 | $65.1M | 0.00% | −12,854−0.7% | Reduced |
| State Street Corp | 2,417,584 | $84.5M | 0.00% | +781,858+47.8% | Added |
| Ra Capital Management, L.P. | 2,629,837 | $91.9M | 1.17% | −2,094,370−44.3% | Reduced |
| BlackRock Inc. | 2,751,705 | $96.2M | 0.00% | +36,033+1.3% | Added |
| Perceptive Advisors LLC | 4,256,104 | $148.8M | 2.62% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 7,150,826 | $250.0M | 0.93% | 00.0% | Unchanged |
| Woodline Partners LP | 0 | $0 | 0.00% | −2,318,576−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −1,530,000−100.0% | Sold out |
| Loomis Sayles & Co L P | 0 | $0 | 0.00% | −1,082,225−100.0% | Sold out |
| Capital Research Global Investors | 0 | $0 | 0.00% | −712,360−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −226,551−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −135,069−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −131,295−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −89,330−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −73,158−100.0% | Sold out |
| HAP Trading, LLC | 0 | $0 | 0.00% | −46,426−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −24,600−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −23,516−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −18,379−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −16,236−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −13,839−100.0% | Sold out |
| Royce & Associates LP | 0 | $0 | 0.00% | −12,995−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −12,666−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Concurrent Investment Advisors, LLC | 0 | $0 | 0.00% | −10,844−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −9,818−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −7,200−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −6,991−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −5,682−100.0% | Sold out |
| West Tower Group, LLC | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| AJOVista, LLC | 0 | $0 | 0.00% | −678−100.0% | Sold out |